BioCryst Pharma

BCRX

----

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: BioCryst Pharma(BCRX) predict that the Revenue is 156.41 M (+7.48%), Beat estimate;the EBIT is -701.6 M (-3405%), Miss estimate;the EPS is -2.98 (--%), Miss estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.16B7.48%

0.15B3.84%

+0.01B3.64%

EBITMiss expectations

-0.70B3405.22%

0.02B9.06%

-0.72B3,396.16%

EPSMiss expectations

-2.98--

0.052--

-3.0320--%

Upcoming earnings report - FY2026 Q2 Earning Release

Available dateAug 5, 2026

Estimate Revenue183.33 M

Estimate EBIT45.29 M

Estimate EPS0.1189

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD